These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11571643)

  • 41. Epidermal growth factor receptor blockade potentiates apoptosis mediated by Paclitaxel and leads to prolonged survival in a murine model of oral cancer.
    Holsinger FC; Doan DD; Jasser SA; Swan EA; Greenberg JS; Schiff BA; Bekele BN; Younes MN; Bucana CD; Fidler IJ; Myers JN
    Clin Cancer Res; 2003 Aug; 9(8):3183-9. PubMed ID: 12912971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced in vitro proliferation and in vivo tumorigenic potential of mammary epithelium from BALB/c mice exposed in vivo to gamma-radiation and/or 7,12-dimethylbenz[a]anthracene.
    Adams LM; Ethier SP; Ullrich RL
    Cancer Res; 1987 Aug; 47(16):4425-31. PubMed ID: 3111686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [EGF-dependent epithelial cells of the mammary cell line HC11 demonstrate a high degree of synchronized cell cycle during stimulation with epidermal growth factor].
    Avrov KO; Aksenov ND; Nikol'skiĭ NN; Kornilova ES
    Tsitologiia; 1998; 40(11):958-63. PubMed ID: 10081091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system.
    Croci S; Recktenwald CV; Lichtenfels R; Nicoletti G; Dressler SP; De Giovanni C; Astolfi A; Palladini A; Shin-ya K; Landuzzi L; Nanni P; Lollini PL; Seliger B
    Proteomics; 2010 Nov; 10(21):3835-53. PubMed ID: 20957756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the growth properties in vitro and transplantability of continuous mouse mammary tumor cell lines and clonal derivatives.
    Butel JS; Dudley JP; Medina D
    Cancer Res; 1977 Jun; 37(6):1892-900. PubMed ID: 192465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4.
    Jackson-Fisher AJ; Bellinger G; Shum E; Duong JK; Perkins AS; Gassmann M; Muller W; Kent Lloyd KC; Stern DF
    Oncogene; 2006 Sep; 25(41):5664-72. PubMed ID: 16652155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Importance of epidermal growth factor in implantation and growth of mouse mammary tumor in female nude mice.
    Tsutsumi O; Tsutsumi A; Oka T
    Cancer Res; 1987 Sep; 47(17):4651-3. PubMed ID: 3497710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p53 mutations in mouse mammary epithelial cells: instability in culture and discordant selection of mutations in vitro versus in vivo.
    Ozbun MA; Medina D; Butel JS
    Cell Growth Differ; 1993 Oct; 4(10):811-9. PubMed ID: 8274450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel anti-ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors.
    Aurisicchio L; Marra E; Luberto L; Carlomosti F; De Vitis C; Noto A; Gunes Z; Roscilli G; Mesiti G; Mancini R; Alimandi M; Ciliberto G
    J Cell Physiol; 2012 Oct; 227(10):3381-8. PubMed ID: 22213458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Morphological and functional properties of TM preneoplastic mammary outgrowths.
    Medina D; Kittrell FS; Liu YJ; Schwartz M
    Cancer Res; 1993 Feb; 53(3):663-7. PubMed ID: 7678778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Viral Ha-ras mediated mammary tumor progression.
    Aguilar-Cordova E; Strange R; Young LJ; Billy HT; Gumerlock PH; Cardiff RD
    Oncogene; 1991 Sep; 6(9):1601-7. PubMed ID: 1923527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer.
    Kondratyev M; Kreso A; Hallett RM; Girgis-Gabardo A; Barcelon ME; Ilieva D; Ware C; Majumder PK; Hassell JA
    Oncogene; 2012 Jan; 31(1):93-103. PubMed ID: 21666715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel orthotopic and metastatic mouse model of breast cancer in human mammary microenvironment.
    Wang J; Xia TS; Liu XA; Ding Q; Du Q; Yin H; Wang S
    Breast Cancer Res Treat; 2010 Apr; 120(2):337-44. PubMed ID: 19350386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin.
    Di Carlo E; Diodoro MG; Boggio K; Modesti A; Modesti M; Nanni P; Forni G; Musiani P
    Lab Invest; 1999 Oct; 79(10):1261-9. PubMed ID: 10532589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice.
    Rovero S; Boggio K; Di Carlo E; Amici A; Quaglino E; Porcedda P; Musiani P; Forni G
    Gene Ther; 2001 Mar; 8(6):447-52. PubMed ID: 11313823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antitumor effect of two oral steroids, mepitiostane and fluoxymesterone, on a pregnancy-dependent mouse mammary tumor (TPDMT-4).
    Matsuzawa A; Yamamoto T
    Cancer Res; 1977 Dec; 37(12):4408-15. PubMed ID: 922732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The genetic penetrance of the activated neu oncogene for the induction of mammary cancer in vivo.
    Tai YT; Gould MN
    Oncogene; 1997 Jun; 14(22):2701-7. PubMed ID: 9178768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spontaneous immunogenicity of ribosomal P0 protein in patients with benign and malignant breast lesions and delay of mammary tumor growth in P0-vaccinated mice.
    Marzocchella L; Sini V; Buonomo O; Orlandi A; Masuelli L; Bonanno E; Lista F; Turriziani M; Manzari V; Roselli M; Modesti A; Bei R
    Cancer Sci; 2011 Mar; 102(3):509-15. PubMed ID: 21175994
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unlimited division potential of precancerous mouse mammary cells after spontaneous or carcinogen-induced transformation.
    Daniel CW; Aidells BD; Medina D; Faulkin LJ
    Fed Proc; 1975 Jan; 34(1):64-7. PubMed ID: 162797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antitumor effect of electrochemical therapy on transplantable mouse cancers.
    Wójcicki M; Droździk M; Olewniczak S; Opolski A; Wietrzyk J; Radzikowski C; Kaczmarek B; Wrzesiński M; Romanowski M; Kamiński M; Zieliński S
    Med Sci Monit; 2000; 6(3):498-502. PubMed ID: 11208360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.